Opioid Use Clinical Trial
Official title:
Safe Opioid Disposal After Surgery Trial
Patients will be randomized to one of two interventions intended to facilitate safe disposal of opioids after cessation following surgery. For pragmatic reasons, participants will be randomized by day to either the information sheet or the disposal bag using a block randomization schedule. To ensuring adequate sample size, patients will be enrolled for a ~4-week period following the 2-week usual care run in period. In the event that the sample size estimate has not been reached after the 4-week intervention period, additional patients will be enrolled accordingly.
The lack of evidence-based guidelines for postoperative opioid prescribing has contributed to
a surplus of opioid pills within our patients' homes and communities, increasing the
potential for diversion and nonmedical use. A recent study suggests that for outpatient
general surgery procedures, roughly 72% of prescribed opioids go unused. Current opioid
disposal options are limited to DEA-authorized opioid collectors, including select law
enforcement agencies, pharmacies, or organized pill drop events, and many patients remain
unaware of these avenues. Several studies have found that few patients have knowledge about
opioid disposal options and even fewer dispose of their unconsumed opioids.
Unconsumed opioids pose a diversion risk. In the 2011 National Survey on Drug Use and Health,
70.8% of those who used a prescription medication non-medically obtained the medication from
a friend or relative, with or without their knowledge. Additionally, nonmedical prescription
opioid use is a common pathway to heroin use. Importantly, over 80% of young intravenous drug
users report initiation of prescription opioid misuse prior to heroin.
Considering that 40% of the prescriptions written by surgeons are for opioids and patients
frequently have excess opioids and limited options for and/or knowledge of opioid disposal,
the present study will provide patients with information and novel options for opioid
disposal as part of the surgical care pathway.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04095624 -
Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion
|
N/A | |
| Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
| Recruiting |
NCT04598074 -
Opioid Package Prototype (OPP)
|
N/A | |
| Recruiting |
NCT06033599 -
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
|
Phase 3 | |
| Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
| Completed |
NCT05845177 -
Persistent Pain After Hip Replacement
|
||
| Completed |
NCT03570320 -
Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Completed |
NCT04526236 -
Influence of Aging on Perioperative Methadone Dosing
|
Phase 4 | |
| Completed |
NCT05593341 -
Opioid Education in Total Knee Arthroplasty
|
N/A | |
| Recruiting |
NCT05877157 -
Pain AND Opioids After Surgery
|
||
| Recruiting |
NCT06055205 -
A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries
|
N/A | |
| Recruiting |
NCT03675386 -
Reducing Opioid Use for Chronic Pain Patients Following Surgery
|
N/A | |
| Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
| Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
| Not yet recruiting |
NCT04868552 -
Naloxone Education in Total Joint Patients
|
N/A | |
| Completed |
NCT03540030 -
Opioid-Free Shoulder Arthroplasty
|
Phase 4 | |
| Terminated |
NCT06217380 -
Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
|
N/A | |
| Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
| Completed |
NCT03472521 -
Prevention of Persistent Opioid Use in Mothers
|
Phase 4 |